The European Union has announced new funding of EUR410 million under its bilateral cooperation with Cambodia over the period 2014-2020 to continue its support to Cambodia's progress.
The funds will help to strengthen agriculture and natural resource management, provide better education and implement governance and administration reforms.
The European Commission said Cambodia has achieved outstanding socio-economic progress over the past 10 years. The majority of the population lifted out of poverty however remains highly vulnerable. The EU decided to increase its support to Cambodia to help the country's ambitions to further reduce poverty, to promote equitable and sustainable growth and to enhance good governance, democracy and the rule of law.
The Commission added that in addition to this bilateral program, Cambodia will continue receiving support under other EU thematic and regional instruments and programs.
For comments and feedback contact: editorial@rttnews.com
Political News
November 03, 2026 10:34 ET A key date in rare disease research. BridgeBio Pharma’s BBP-418 is under FDA Priority Review for limb-girdle muscular dystrophy type 2I/R9, a rare genetic disease with no approved treatment. The FDA decision is targeted for November 27. If approved, BBP-418 could become the first approved therapy for any form of limb-girdle muscular dystrophy.